Method for producing uridine through enzyme catalysis and application
E. coli expresses cytidine deaminase cdd for enzyme catalysis, and uses cheap cytidine to achieve efficient production of uridine, solving the high cost and by-product problems of existing uridine production methods, achieving high conversion rate and low cost industrial production.
Patent Information
- Application Number
- CN202411293766.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-14
- Publication Date
- 2024-11-29
AI Technical Summary
The existing uridine production methods have problems such as high production costs, environmental pollution, many by-products and complex industries. In particular, the uridine production of microbial fermentation methods is low and the by-products are difficult to separate, which limits its industrial applications.
E. coli is used to efficiently express cytidine deaminase cdd for enzyme catalysis, and use inexpensive cytidine as raw material to improve the enzyme conversion efficiency and shorten the catalytic time through cytidine deaminase mutants, so as to achieve efficient production of uridine.
It has achieved efficient production of uridine, with a conversion rate of up to 99.67%, simple process and low cost, suitable for large-scale industrial production, shortened catalytic time, and significantly improved the production intensity of enzyme-catalyzed uridine.
Smart Images

Figure CN119040416A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the field of biotechnology, and in particular to a method for producing uridine catalyzed by enzyme and its application. Background Art
[0002] Uridine (uridine nucleoside) is a natural nucleoside compound with a molecular weight of 244.2. Uridine is a white needle-shaped crystal or powder, odorless, slightly sweet and slightly spicy, soluble in water, slightly soluble in dilute alcohol, insoluble in anhydrous ethanol, and has a solubility of 50 g / L in water. The density of uridine is 1.674 g / cm 3 , melting point is 165-170℃. Guanylic acid, a derivative of uridine, is one of the four nucleotides that make up RNA and has important physiological functions. Uridine participates in the synthesis of cellular polysaccharides and has the medicinal value of improving the cell's tolerance to hypoxia and reducing cytotoxicity. The combination of uridine and inosine can promote the energy metabolism of brain cells, improve the physiological function of the nervous system, and improve sleep quality. As a neuroprotectant, uridine can slow down brain aging and prevent cognitive dysfunction such as dementia. Uridine can also increase the production and release of dopamine, making people happy, and can be used to treat depression. Uridine can be used as a clinical drug and can also be used to treat liver, cardiovascular and cerebrovascular diseases.
[0003] At present, the production methods of uridine mainly include RNA hydrolysis, chemical synthesis, and microbial fermentation. RNA hydrolysis was a method used in history to produce uridine, but it is no longer used due to production costs, environmental pollution, yield, and other reasons. There are many synthesis processes for chemical synthesis, which are used for the industrial production of uridine. However, due to the disadvantages of chemical synthesis in the production of uridine, such as large environmental pollution, many by-products, and complex industry, the chemical synthesis method for the production of uridine has been basically discontinued. There have been reports on the use of microorganisms to produce uridine, mainly focusing on the use of Bacillus subtilis, mutation breeding and genetic engineering to increase the production of uridine. Japanese researchers Tsunemi Y et al. conducted mutation breeding on Bacillus subtilis and screened out the high-yield uridine strain No. 556, whose maximum yield can reach 55 g / L (United States: 4880736). However, domestic scholars used the same method to breed strains, and their uridine production was only 4.0 g / L (Cheng Yuanchao, et al. Modern Food Science and Technology, 2007, 1: 20-22). It can be inferred that the Japanese researchers did not fully disclose the key metabolic and regulatory issues that need to be solved for high uridine production. The researchers used Bacillus subtilis 168 and its engineered bacteria as the starting bacteria, and through multiple metabolic engineering modifications and fermentation condition optimization, they constructed strain F126-2. After 48 hours of fermentation, the uridine production can reach 40.62 g / L (Yuan Hui, Tianjin University of Science and Technology, 2017). However, this production strain has two major defects: the fermentation carbon source consumption is large and the yield is low, resulting in low raw material costs for uridine production; with the synthesis of uridine, a large amount of by-products, hydroxybutanone, are produced, which is difficult to effectively separate by existing separation and purification methods. These two major defects limit the application of this strain in the industrial production of uridine.
[0004] Therefore, in order to achieve efficient production of uridine, it is crucial to provide an enzyme-catalyzed method for producing uridine with high substrate conversion rate, no by-products, short catalytic time and simple process. Summary of the invention
[0005] In view of the above-mentioned shortcomings of the prior art, the object of the present invention is to provide a method and application of enzymatically producing uridine, using Escherichia coli to efficiently express cytidine deaminase cdd , using enzyme catalysis, using cheap cytidine as raw material, to achieve efficient production of uridine; in addition, the present invention will also provide cytidine deaminase cdd mutants to further improve the efficiency of enzyme conversion of substrates and shorten the catalytic time.
[0006] In order to achieve the above-mentioned object and other related objects, the present invention provides the following technical solutions: In a first aspect of the present invention, a cytidine deaminase is provided. cddApplication of cytidine deaminase in catalyzing the production of uridine from cytidine cdd The amino acid sequence is shown in SEQ ID NO.1.
[0007] In one embodiment of the present invention, the cytidine deaminase is encoded cdd The nucleotide sequence is shown in SEQ ID NO.2.
[0008] In a second aspect of the present invention, a cytidine deaminase mutant is provided for use in catalyzing cytidine to produce uridine. The cytidine deaminase mutant is the cytidine deaminase cdd The mutants of cytidine deaminase are short peptides consisting of 6 amino acid residues at the C-terminus. 289 DRVLLA 294 Truncate and cut separately 293 LA 294 , 291 VLLA 294 , 289 DRVLLA 294 , construct a cytidine deaminase mutant cdd -M1, cdd -M2, cdd -M3. The cytidine deaminase mutant can further improve the efficiency of enzyme substrate conversion and shorten the catalytic time.
[0009] Among them, the cdd -M1 amino acid sequence is shown in SEQ ID NO.3, cdd -M2 amino acid sequence is shown in SEQ ID NO.5, cdd The amino acid sequence of -M3 is shown in SEQ ID NO.7.
[0010] In one embodiment of the present invention, the encoding cdd -M1 nucleotide sequence is shown in SEQ ID NO.4, encoding the cdd -M2 nucleotide sequence is shown in SEQ ID NO.6, encoding the cdd The nucleotide sequence of -M3 is shown in SEQ ID NO.8.
[0011] The third aspect of the present invention provides a method for producing uridine by enzyme catalysis, the method comprising: treating the amino acid sequence of cytidine deaminase shown in SEQ ID NO. cdd , or expresses cytidine deaminase with an amino acid sequence as shown in SEQ ID NO.1 cddA recombinant bacterium, or a cytidine deaminase mutant with an amino acid sequence as shown in SEQ ID NO.3, SEQ ID NO.5 or SEQ ID NO.7, or a recombinant bacterium expressing a cytidine deaminase mutant with an amino acid sequence as shown in SEQ ID NO.3, SEQ ID NO.5 or SEQ ID NO.7, is added to a reaction system containing a substrate cytidine and a sodium phosphate buffer for reaction to prepare uridine.
[0012] In one embodiment of the present invention, the cytidine deaminase is encoded cdd The nucleotide sequence is shown as SEQ ID NO.2; the nucleotide sequence encoding the cytidine deaminase mutant is shown as SEQ ID NO.4, SEQ ID NO.6 or SEQ ID NO.8.
[0013] In one embodiment of the present invention, the cytidine deaminase cdd The preparation method is: (1) Primer design cdd -FW and cdd -RS, PCR amplified nucleotide sequence as shown in SEQ ID NO.2 cytidine deaminase cdd cytidine deaminase cdd The gene was connected to the plasmid pRSFDuet-1 using the restriction sites Nco I and EcoR I to obtain the recombinant plasmid pRSFDuet-1- cdd ; (2) Recombinant plasmid pRSFDuet-1- cdd Transform into host bacteria to prepare recombinant bacteria; (3) Inducing fermentation of the recombinant bacteria, homogenizing and crushing by centrifugation to obtain cytidine deaminase cdd .
[0014] In one embodiment of the present invention, the preparation method of the cytidine deaminase mutant is: (1) Using the recombinant plasmid pRSFDuet-1- cdd As a template, primers were designed for PCR amplification, and the template was digested with Dpn I restriction endonuclease to obtain the recombinant plasmid; (2) Transforming the recombinant vector into a host bacterium to prepare a recombinant bacterium; (3) Inducing fermentation of the recombinant bacteria, homogenizing and crushing the bacteria, and centrifuging to obtain a cytidine deaminase mutant.
[0015] In one embodiment of the present invention, the cytidine deaminase cdd The primer sequences are shown in SEQ ID NO.9 and SEQ ID NO.10; The cytidine deaminase mutantcdd - The primer sequences of M1 are shown in SEQ ID NO.11 and SEQ ID NO.12; The cytidine deaminase mutant cdd - The primer sequences of M2 are shown in SEQ ID NO.13 and SEQ ID NO.14; The cytidine deaminase mutant cdd The primer sequences of -M3 are shown in SEQ ID NO.15 and SEQ ID NO.16.
[0016] In one embodiment of the present invention, the concentration of the sodium phosphate buffer is 0.1 M, and the pH of the sodium phosphate buffer is 7.0.
[0017] In one embodiment of the present invention, the concentration of the substrate cytidine is 100 g / L-200 g / L.
[0018] In one embodiment of the present invention, cytidine deaminase cdd Or the added amount of cytidine deaminase mutant is 1%~8w / w%, preferably 1%~2w / w%.
[0019] Preferably, 1 mL of enzyme is added per 100 mL of the system.
[0020] In one embodiment of the present invention, the reaction temperature is 20-30°C; preferably, the reaction temperature is 25°C.
[0021] In a fourth aspect of the present invention, a cytidine deaminase having a nucleotide sequence as shown in SEQ ID NO.2 is provided. cdd Gene, or cytidine deaminase containing the nucleotide sequence as shown in SEQ ID NO.2 cdd A recombinant plasmid containing a gene, or a cytidine deaminase containing a nucleotide sequence as shown in SEQ ID NO.2 cdd A recombinant bacterium containing a gene, or a cytidine deaminase mutant gene with a nucleotide sequence as shown in SEQ ID NO.4, SEQ ID NO.6 or SEQ ID NO.8, or a recombinant plasmid containing a cytidine deaminase mutant gene with a nucleotide sequence as shown in SEQ ID NO.4, SEQ ID NO.6 or SEQ ID NO.8, or a recombinant bacterium containing a cytidine deaminase mutant gene with a nucleotide sequence as shown in SEQ ID NO.4, SEQ ID NO.6 or SEQ ID NO.8, in catalyzing the production of uridine or a product containing uridine.
[0022] As described above, the method and application of the present invention for producing uridine by enzyme catalysis have the following beneficial effects: 1. The present invention uses recombinant expression technology to express cytidine deaminase cddOverexpression to obtain excess cytidine deaminase cdd Using cheap cytidine as raw material, the efficient conversion of high-concentration substrate cytidine is achieved, with a conversion rate of up to 99.67%. The substrate can be completely converted, and efficient production of uridine is obtained. The process of the present invention is simple, the conditions are simple, the cost is low, and it is suitable for large-scale industrial production.
[0023] 2. The present invention is a short peptide consisting of 6 amino acid residues at the C-terminus of wild cytidine deaminase 289 DRVLLA 294 Truncate and cut separately 293 LA 294 , 291 VLLA 294 , 289 DRVLLA 294 , construct a cytidine deaminase mutant cdd -M1, cdd -M2, cdd -M3, the cytidine deaminase mutant can further improve the efficiency of the enzyme in converting the substrate cytidine, with a conversion rate of 99.81%. The cytidine deaminase mutant can shorten the catalytic time to 20 minutes, which can promote the application of cytidine deaminase in medicine and other fields. BRIEF DESCRIPTION OF THE DRAWINGS
[0024] Figure 1 The cytidine deaminase gene obtained by PCR in Example 1 cdd Fragment gel electrophoresis.
[0025] Figure 2 Cytidine deaminase in the recombinant bacteria in Example 2 cdd SDS-PAGE image of.
[0026] Figure 3 This is the HPLC chart of the enzymatic production of uridine in Example 3.
[0027] Figure 4 Cytidine deaminase cdd The three-level structure model. DETAILED DESCRIPTION
[0028] The following is a description of the implementation of the present invention by means of specific embodiments. Those skilled in the art can easily understand other advantages and effects of the present invention from the contents disclosed in this specification.
[0029] The HPLC detection conditions of uridine involved in the following examples are: liquid chromatograph Shimadzu 10A, chromatographic column: INERTSILODS-SP 5μm 4.6*250 mm, mobile phase: buffer preparation: 0.1 mol / L potassium dihydrogen phosphate aqueous solution: 0.01 mol / L tetrabutylammonium hydroxide: methanol = 95:95:10, then adjust the pH to 4.5 with phosphoric acid, wavelength: 276 nm, flow rate: 1.0 mL / min.
[0030] The enzyme catalytic reaction conditions involved in the following examples are: 0.1 M sodium phosphate buffer (pH=7.0), the concentration of substrate cytidine is 100 g / L, the amount of enzyme added is 1 mL, the reaction system is 100 mL, and the reaction temperature is 25°C.
[0031] In the following examples, the enzyme activity is defined as follows: under the above catalytic conditions, the amount of uridine generated per minute is 1 enzyme activity unit (U).
[0032] The strains involved in the following examples are shown in Table 1: Table 1. Strains involved in the examples
[0033] The strains involved in the following examples are shown in Table 2: Table 2. Primers
[0034] Example 1: Recombinant E. coli pRSFDuet-1- cdd Construction Design primers with sequences as shown in SEQ ID NO.9 and SEQ ID NO.10 cdd -FW and cdd -RS, PCR amplification of cytidine deaminase from Escherichia coli cdd Gene (nucleotide sequence is shown in SEQ ID NO.2). Cytidine deaminase obtained by PCR cdd Gel electrophoresis of gene fragments Figure 1 As shown, PCR amplification conditions: pre-denaturation at 98°C for 5 min; denaturation at 95°C for 30 s; annealing at 55°C for 30 s; extension at 72°C (enzyme extension rate is 1 kb / min, the specific time is set according to the length of the amplified fragment); set the cycle to 30 times; re-extension at 72°C for 10 min; and finally insulation at 16°C. PCR amplification system: 5×PS buffer 20 μL, dNTP 10 μL, upstream / downstream primers (10 μmol·L -1 ) 2 μL, template 1 μL, enzyme 1 μL, water 66 μL.
[0035] Cytidine deaminase cdd The gene was connected to the plasmid pRSFDuet-1 using restriction sites Nco I and EcoR I to obtain the recombinant plasmid pRSFDuet-1- cdd At the same time, the sequence was sent to a sequencing company for sequencing verification. cdd The recombinant plasmid pRSFDuet-1- cdd .
[0036] The recombinant plasmid pRSFDuet-1- cdd Introduced into Escherichia coli BL21 to produce a bacterium expressing cytidine deaminase cdd Gene recombinant bacteria E. coli pRSFDuet-1- cdd .
[0037] Example 2: Cytidine Deaminase cdd Expression The recombinant bacteria prepared in Example 1 E. coli pRSFDuet-1- cdd Inoculate into LB liquid medium and culture at 37°C and 200 rpm for 8 h to prepare seed solution. Inoculate the seed solution into TB liquid medium at a 1% (v / v) inoculation rate and ferment at 37°C until OD 600 =0.6, add 0.5 mL of inducer IPTG with a final concentration of 1.0 mM, induce fermentation at 28°C for 24 h, and prepare fermentation broth.
[0038] The fermentation liquid was centrifuged to obtain bacterial cells, and the bacterial cells were broken by ultrasonic disruption. After the broken bacterial cells were centrifuged, the supernatant of the broken cells was taken for agarose-gel electrophoresis analysis. Figure 2 The results showed that in the recombinant bacteria E. coli pRSFDuet-1- cdd Cytidine deaminase was successfully expressed in the fermentation broth of cdd (31.5 kDa).
[0039] The cytidine deaminase in the supernatant was determined by enzyme activity assay. cdd The enzyme activity reached 201.8U / mL.
[0040] Example 3: Cytidine Deaminase cdd Method for catalyzing cytidine to produce uridine Cytidine deaminase produced by fermentation in Example 2 cddThe enzyme solution was used to catalyze cytidine to produce uridine by enzyme catalysis. The enzyme catalytic reaction conditions were: 0.1 M sodium phosphate buffer (pH = 7.0), the concentration of substrate cytidine was 100 g / L, the amount of enzyme added was 1 mL, the reaction system was 100 mL, and the reaction temperature was 25°C. The uridine conversion rate was 72.4% after 20 minutes of catalysis, and the reaction was complete after 30 minutes of catalysis. Figure 3 In the HPLC graph, the peak at 6.207 min is uridine, and cytidine is almost completely catalyzed to produce uridine with a conversion rate of 99.67%. The results show that the technical route of catalyzing cytidine to produce uridine is feasible and efficient.
[0041] Example 4: Optimizing the catalytic process The two parameters of cytidine concentration and cytidine deaminase addition were optimized, including cytidine concentration (100 g / L, 200 g / L) and enzyme addition (0.1%, 1%, 2%, 8%). The results are shown in Table 3. When the cytidine concentration was 100 g / L (10%) and the enzyme addition amount was 1%, 2%, and 8% for 30 minutes, cytidine could be completely catalyzed to produce uridine, and the conversion rate was more than 99%. However, when the enzyme addition amount was 0.1% and the substrate concentration was 200 g / L (20%), when the reaction time was 4 h, the enzyme conversion rate was only 59.27%, which should be caused by too little enzyme and too high substrate concentration.
[0042] Table 3. Conversion rate of cytidine under different conditions
[0043] Example 5: Construction of cytidine deaminase mutants In order to further improve the efficiency of enzyme conversion of substrates and shorten the catalytic time, the present invention is directed to cytidine deaminase cdd First, the tertiary structure of the enzyme was homologously modeled using the SWISS-MODEL software, and the following Figure 4 Cytidine deaminase cdd The tertiary structure model of cytidine deaminase cdd The tertiary structure model of the peptide was analyzed to determine the short peptide consisting of 6 amino acid residues at its C-terminus. 289 DRVLLA 294 Truncate and cut separately 293 LA 294 , 291 VLLA 294 , 289 DRVLLA 294 , construct a cytidine deaminase mutant cdd -M1, cdd -M2, cdd -M3.
[0044] The specific construction method is: the recombinant plasmid pRSFDuet-1- cdd As templates, primers M1-FW and M1-RS (sequences shown in SEQ ID NO.11 and SEQ ID NO.12), M2-FW and M2-RS (sequences shown in SEQ ID NO.13 and SEQ ID NO.14), M3-FW and M3-RS (sequences shown in SEQ ID NO.15 and SEQ ID NO.16) were used for PCR amplification to obtain the truncated gene. cdd The recombinant plasmid fragment was digested with Dpn I restriction endonuclease. The competent E. coli BL21 cells were transformed to screen for mutants containing cytidine deaminase. cdd -M1, cdd -M2, cdd -M3 gene recombinant bacteria: E. coli pRSFDuet-1- cdd-M1 , E. coli pRSFDuet-1- cdd-M2 , E. coli pRSFDuet-1- cdd-M3 .
[0045] The three recombinant bacteria were inoculated into LB liquid medium, respectively, and cultured at 37°C and 200 rpm for 8 h to prepare seed solution. The seed solution was inoculated into TB liquid medium at an inoculum rate of 1% (v / v) and fermented at 37°C until OD 600 =0.6, add 0.5 mL of inducer IPTG with a final concentration of 1.0 mM, induce fermentation at 28°C for 24 h, and prepare fermentation broth. Centrifuge the fermentation broth to obtain bacterial cells, and use ultrasonic disruption to break the bacterial cells. Centrifuge the broken bacterial cells and take the supernatant of the broken cells.
[0046] The enzyme activity of the cytidine deaminase mutant in the cell-broken supernatant was determined by the above enzyme activity determination method. E. coli pRSFDuet-1- cdd-M1 , E. coli pRSFDuet-1- cdd-M2 , E. coli pRSFDuet-1- cdd-M3 Cytidine deaminase mutants in cdd -M1, cdd -M2, cdd -M3's enzyme activities were 195.3 U / mL, 266.8 U / mL, and 115.1 U / mL, respectively.
[0047] Example 6: Method for producing uridine from cytidine by catalyzing cytidine with cytidine deaminase mutant The recombinant bacteria in Example 5 E. coli pRSFDuet-1- cdd-M2 Fermentation-produced cytidine deaminase mutants cdd -M2 enzyme solution was used to catalyze cytidine to produce uridine using an enzyme catalytic method. The enzyme catalytic reaction conditions were: 0.1 M sodium phosphate buffer (pH = 7.0), the concentration of substrate cytidine was 100 g / L, the amount of enzyme added was 1 mL, the reaction system was 100 mL, and the reaction temperature was 25°C. After 20 minutes of catalysis, cytidine was almost completely catalyzed to uridine, with a conversion rate of 99.81%, which was comparable to that of wild cytidine deaminase. cdd The conversion rate of the catalytic cytidine deaminase mutant was only 72.4% at 20 min (Example 3). cdd -M2 has a shorter catalytic time and higher conversion rate, which significantly improves the production intensity of enzyme-catalyzed cytidine to produce uridine.
[0048] Under the same catalytic conditions, the recombinant bacteria in Example 5 were respectively E. coli pRSFDuet-1- cdd-M1 and E. coli pRSFDuet-1- cdd-M3 Fermentation-produced cytidine deaminase mutants cdd -M1 enzyme solution and cdd -M3 enzyme solution, using enzyme catalysis to catalyze cytidine to produce uridine. After 20 minutes of catalysis, cdd -M1 and cdd -M3 converted cytidine to uridine with conversion rates of 76.2% and 81.3%, respectively, which were better than those of wild-type cdd , but with cdd -M2, the conversion rate is low, which further proves cdd -M2 has the best effect.
[0049] In summary, the present invention converts the amino acid sequence of cytidine deaminase shown in SEQ ID NO.1 into cdd , or expression of cytidine deaminase cdd The recombinant bacteria, or the cytidine deaminase mutants with amino acid sequences as shown in SEQ ID NO.3, SEQ ID NO.5 or SEQ ID NO.7, or the recombinant bacteria expressing the cytidine deaminase mutants are added to the reaction system containing the substrate cytidine and sodium phosphate buffer for reaction, so as to prepare uridine. The present invention adopts the recombinant expression technology to express cytidine deaminase cdd Overexpression to obtain excess cytidine deaminase cdd,Using cheap cytidine as raw material, the efficient conversion of high-concentration substrate cytidine is achieved, and the efficient production of uridine is obtained, and the process is simple, the cost is low, and it is suitable for large-scale industrial production; in addition, the present invention constructs and obtains a cytidine deaminase mutant, further improves the efficiency of the enzyme conversion substrate cytidine, and shortens the catalytic time, promoting the application of cytidine deaminase in the fields of medicine and the like. Therefore, the present invention effectively overcomes various shortcomings in the prior art and has a high industrial utilization value.
[0050] The above embodiments are merely illustrative of the principles and effects of the present invention, and are not intended to limit the present invention. Anyone familiar with the art may modify or alter the above embodiments without departing from the spirit and scope of the present invention. Therefore, all equivalent modifications or alterations made by a person of ordinary skill in the art without departing from the spirit and technical concept disclosed by the present invention shall still be covered by the claims of the present invention.
Claims
1. A cytidine deaminase cd The use of the method for catalyzing cytidine to produce uridine is characterized in that: The cytidine deaminase cd The amino acid sequence is shown in SEQ ID NO.
1.
2. The use according to claim 1, characterized in that: Encoding the cytidine deaminase cd The nucleotide sequence is shown in SEQ ID NO.
2.
3. Use of a cytidine deaminase mutant in catalyzing the production of uridine from cytidine, characterized in that: The cytidine deaminase mutants include cd -M1, cd -M2, cd -M3, cd -M1 amino acid sequence is shown in SEQ ID NO.3, cd -M2 amino acid sequence is shown in SEQ ID NO.5, cd The amino acid sequence of -M3 is shown in SEQ ID NO.
7.
4. The use according to claim 3, characterized in that: Encoding cd -M1 nucleotide sequence is shown in SEQ ID NO.4, encoding the cd -M2 nucleotide sequence is shown in SEQ ID NO.6, encoding the cd The nucleotide sequence of -M3 is shown in SEQ ID NO.
8.
5. A method for producing uridine by enzyme catalysis, characterized in that: The amino acid sequence of cytidine deaminase is shown in SEQ ID NO. cd , or expresses cytidine deaminase with an amino acid sequence as shown in SEQ ID NO.1 cd A recombinant bacterium, or a cytidine deaminase mutant with an amino acid sequence as shown in SEQ ID NO.3, SEQ ID NO.5 or SEQ ID NO.7, or a recombinant bacterium expressing a cytidine deaminase mutant with an amino acid sequence as shown in SEQ ID NO.3, SEQ ID NO.5 or SEQ ID NO.7, is added to a reaction system containing a substrate cytidine and a sodium phosphate buffer for reaction to prepare uridine.
6. The method according to claim 5, characterized in that The cytidine deaminase cd The preparation method is: (1) Primer design cd -FW and cd -RS, PCR amplified nucleotide sequence as shown in SEQ ID NO.2 cytidine deaminase cd cytidine deaminase cd The gene was connected to the plasmid pRSFDuet-1 using restriction sites Nco I and EcoR I to obtain the recombinant plasmid pRSFDuet-1- cd ; (2) Recombinant plasmid pRSFDuet-1- cd Transform into host bacteria to prepare recombinant bacteria; (3) Inducing fermentation of the recombinant bacteria, homogenizing and crushing by centrifugation to obtain cytidine deaminase cd .
7. The method according to claim 6, characterized in that The preparation method of the cytidine deaminase mutant is: (1) Using the recombinant plasmid pRSFDuet-1- cd As a template, primers were designed for PCR amplification, and the template was digested with Dpn I restriction endonuclease to obtain the recombinant plasmid; (2) Transforming the recombinant vector into a host bacterium to prepare a recombinant bacterium; (3) Inducing fermentation of the recombinant bacteria, homogenizing and crushing the bacteria, and centrifuging to obtain a cytidine deaminase mutant.
8. The method according to claim 5, characterized in that The concentration of sodium phosphate buffer is 0.1 M, and the pH of sodium phosphate buffer is 7.
0.
9. The method according to claim 5, characterized in that The added amount of cytidine deaminase cdd or cytidine deaminase mutant is 1%~8w / w%.
10. Cytidine deaminase having a nucleotide sequence as shown in SEQ ID NO.2 cd Gene, or cytidine deaminase containing the nucleotide sequence as shown in SEQ ID NO.2 cd A recombinant plasmid containing a gene, or a cytidine deaminase containing a nucleotide sequence as shown in SEQ ID NO.2 cd A recombinant bacterium containing a gene, or a cytidine deaminase mutant gene with a nucleotide sequence as shown in SEQ ID NO.4, SEQ ID NO.6 or SEQ ID NO.8, or a recombinant plasmid containing a cytidine deaminase mutant gene with a nucleotide sequence as shown in SEQ ID NO.4, SEQ ID NO.6 or SEQ ID NO.8, or a recombinant bacterium containing a cytidine deaminase mutant gene with a nucleotide sequence as shown in SEQ ID NO.4, SEQ ID NO.6 or SEQ ID NO.8, in catalyzing the production of uridine or a product containing uridine.
